Michael Chisamore is currently an Executive Director and Distinguished Scientist in Oncology Clinical Research and Early Development at Merck, a position they have held since 2018. They previously served in various roles at Merck from 2009 to 2014, including Oncology Clinical Science Liaison and Director of Scientific Affairs. Michael is pursuing a Ph.D. in Cellular and Molecular Pharmacology at the University of Medicine and Dentistry of New Jersey and Rutgers, as well as a Master's in Biotechnology from the University of Pennsylvania, while holding a Bachelor of Science in Biology from Indiana University Bloomington.
This person is not in the org chart
This person is not in any teams
This person is not in any offices